Role of dietary fiber and short-chain fatty acids in the colon

被引:153
作者
Andoh, A [1 ]
Tsujikawa, T [1 ]
Fujiyama, Y [1 ]
机构
[1] Shiga Univ Med Sci, Div Gastroenterol, Otsu, Shiga 5202192, Japan
关键词
IBD; complement; decay-accelerating factor; NF-kappa B; fermentation; colon cancer;
D O I
10.2174/1381612033391973
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Luminal nutrition is important for maintenance of gastrointestinal mucosal structure and function. In particular, short chain fatty acids (SCFAs), metabolic products of anaerobic bacterial fermentation of dietary fiber and resistant starch, are particularly important as the preferred respiratory fuel of the colonocytes. A variety of biological effects of SCFAs have been reported, and there is now increasing number of experimental works showing new aspects of these molecules. For example, as the mechanisms mediating anti-inflammatory effects of SCFAs, 347 several investigators identified the inhibitory effect of butyrate on proinflammatory cytokine-induced NF-kappaB activation. Various inflammatory responses are now discussed with the central role of NF-kappaB activation, and thus the inhibition of NF-kappaB activation represents the efficacy of dietary fiber and SCFAs in the treatment with inflammatory bowel disease. Furthermore, recent advance in molecular technology has identified mechanisms mediating anti-tumor effects of SCFAs. SCFAs modulate expression of cell cycle-regulating proteins and induce apoptosis in colon cancer cells. SCFAs increase the susceptibility of colon cancer cells to complement-mediated cell injury. In this review, new aspects of functions of SCFAs are focused and summarized.
引用
收藏
页码:347 / 358
页数:12
相关论文
共 112 条
  • [81] ROLE OF ANAEROBIC-BACTERIA IN THE METABOLIC WELFARE OF THE COLONIC MUCOSA IN MAN
    ROEDIGER, WEW
    [J]. GUT, 1980, 21 (09) : 793 - 798
  • [82] ROMBEAU JL, 1990, INT CONGR SER, V836, P201
  • [83] RYAN GP, 1979, GASTROENTEROLOGY, V77, P658
  • [84] EFFECT OF BUTYRATE ENEMAS ON THE COLONIC MUCOSA IN DISTAL ULCERATIVE-COLITIS
    SCHEPPACH, W
    SOMMER, H
    KIRCHNER, T
    PAGANELLI, GM
    BARTRAM, P
    CHRISTL, S
    RICHTER, F
    DUSEL, G
    KASPER, H
    [J]. GASTROENTEROLOGY, 1992, 103 (01) : 51 - 56
  • [85] FACTORS CONTRIBUTING TO LEAKAGE OF COLONIC ANASTOMOSIS
    SCHROCK, TR
    DEVENEY, CW
    DUNPHY, JE
    [J]. ANNALS OF SURGERY, 1973, 177 (05) : 513 - 518
  • [86] Butyrate inhibits inflammatory responses through NFκB inhibition:: implications for Crohn's disease
    Segain, JP
    de la Blétière, DR
    Bourreille, A
    Leray, V
    Gervois, N
    Rosales, C
    Ferrier, L
    Bonnet, C
    Blottière, HM
    Galmiche, JP
    [J]. GUT, 2000, 47 (03) : 397 - 403
  • [87] Probiotics and inflammatory bowel disease: Is there a scientific rationale?
    Shanahan, F
    [J]. INFLAMMATORY BOWEL DISEASES, 2000, 6 (02) : 107 - 115
  • [88] Therapeutic manipulation of gut flora
    Shanahan, F
    [J]. SCIENCE, 2000, 289 (5483) : 1311 - 1312
  • [89] Shih A, 2001, MICROSC MICROANAL, V7, P13, DOI 10.1007/s100050010053
  • [90] Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells:: induction of cyclin D3 and p21 expression
    Siavoshian, S
    Segain, JP
    Kornprobst, M
    Bonnet, C
    Cherbut, C
    Galmiche, JP
    Blottière, HM
    [J]. GUT, 2000, 46 (04) : 507 - 514